Abstract
Obstructive sleep apnea (OSA) is associated with coronary artery disease (CAD) and heart failure. During apneic spells, sympathetic nerve activity increases which is thought to contribute to this association. Beta-blocker (BB) medications block this sympathetic nerve activity. We studied the role of
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
